Side-by-side comparison
AOD-9604 vs Tirzepatide — Price & Profile Comparison
AOD-9604
Cellular PeptideLipolysis research
Tirzepatide
GIP/GLP-1 PeptideMetabolic / weight research
The short answer
AOD-9604 vs Tirzepatide: which to choose
Tirzepatide is the cheaper option — roughly $12 vs $57 for the lowest verified listing. Tirzepatide is the more widely stocked of the two (52 vendors vs 26). They target different goals — AOD-9604 is a cellular peptide compound while Tirzepatide is a gip/glp-1 peptide one — so they're often complementary rather than direct substitutes.
Research products are not for human use. Looking for clinician-supervised care instead? Compare licensed US telehealth providers, published prices, plan terms, and state availability.
Compare supervised options →Price Comparison — 2026
AOD-9604
Tirzepatide
Vendors Carrying Both
20 vendors stock both AOD-9604 and Tirzepatide — convenient if you want to bundle an order.
Safety Notes
AOD-9604
FDA: Not FDA-approved (GRAS in AU)
6+ RCTs, 900+ participants; no IGF-1 or glucose effects; excellent tolerability; GRAS status in Australia
Tirzepatide
FDA: FDA-approved (Mounjaro/Zepbound)
Extensive Phase III data; GI side effects manageable; thyroid warning animal-only; strong efficacy
Explore Further
AOD-9604
Tirzepatide